Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,outcome_id,subgroup_id,outcome_name,subgroup_name
1.1 Mortality at 12 months' follow‐up Show forest plot,14,9924,"Risk Ratio (M‐H, Random, 95% CI)","0.98 [0.84, 1.15]",Case management compared with usual care for mortality,1,1,1,,Mortality at 12 months' follow‐up Show forest plot
1.2 Mortality between 6 and 36 months' follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for mortality,1,1,2,,Mortality between 6 and 36 months' follow‐up Show forest plot
Mortality between 6 and 36 months' follow‐up,Mortality between 6 and 36 months' follow‐up,Mortality between 6 and 36 months' follow‐up,,,Case management compared with usual care for mortality,1,Mortality,,between 6 and 36 m,
Study,Results,Notes,,,Case management compared with usual care for mortality,1,Study,,,
Applebaum 2002,Number of individuals who died IG: 5/88; CG: 4/67,Number of participants at baseline: intervention group (IG): 88; control group (CG): 67. Follow‐up: 6 months.,,,Case management compared with usual care for mortality,1,Applebaum,,,
Kono 2012,Number of individuals who died IG: 11/161; CG: 20/162,Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Follow‐up: baseline–24 months.,,,Case management compared with usual care for mortality,1,Kono,,,
Kono 2016,Number of individuals who died 12–24 months: IG: 12/171; CG: 2/172 24–36 months: IG: 7/158; CG: 10/168,Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Follow‐up: 12–24 months and 24–36 months.,,,Case management compared with usual care for mortality,1,Kono,,,
Metzelthin 2013,Number of individuals who died IG: 6/157; CG: 7/141,Number of participants at baseline: intervention group (IG): 193; control group (CG): 153. Follow‐up: 12–24 months.,,,Case management compared with usual care for mortality,1,Metzelthin,,,
Parsons 2012,Number of individuals who died IG: 10/117; CG: 13/116,Number of participants at baseline: intervention group (IG): 169; control group (CG): 182. Follow‐up: 12–24 months.,,,Case management compared with usual care for mortality,1,Parsons,,,
Suijker 2016,Number of individuals who died IG: 56/936; CG: 46/817,Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1074. Follow‐up: 12–24 months.,,,Case management compared with usual care for mortality,1,Suijker,,,
van Hout 2010,Number of individuals who died IG: 27/331; CG: 31/320,Number of participants at baseline: intervention group (IG): 331; control group (CG): 320. Follow‐up: 18 months.,,,Case management compared with usual care for mortality,1,van,,,
2.1 Change in place of residence to a nursing home at 12 months follow‐up Show forest plot,4,1108,"Risk Ratio (M‐H, Random, 95% CI)","0.73 [0.53, 1.01]",Case management compared with usual care for change in place of residence to a nursing or residential home,3,2,1,,Change in place of residence to a nursing home at 12 months follow‐up Show forest plot
"2.2 Change in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 months' follow‐up Show forest plot",0,,Other data,No numeric data,Case management compared with usual care for change in place of residence to a nursing or residential home,3,2,2,,"Change in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 months' follow‐up Show forest plot"
"Change in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 months' follow‐up","Change in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 months' follow‐up","Change in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 months' follow‐up",,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Change,,"in place of residence to nursing or residential home, and days spent in a nursing home or home for the aged, between 6 and 24 m",
Study,Results,Notes,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Study,,,
Applebaum 2002,Nursing home admissions 6 months: IG: 8/156; CG: 12/152 From 12 to 18 months: IG: 16/111; CG: 17/108,"Number of participants at baseline: intervention group (IG): 156; control group (CG): 152. Follow‐up: 6 months, 12–18 months.",,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Applebaum,,,
Dalby 2000,Nursing home admissions IG: 0/73; CG: 1/69,Number of participants at baseline: intervention group (IG): 73; control group (CG): 69. Follow‐up: 14 months.,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Dalby,,,
Kono 2012,Nursing home admissions (institutionalised) IG: 5/161; CG: 3/162,Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Follow‐up: 24 months.,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Kono,,,
Kono 2016,Nursing home admissions (institutionalised) IG: 5/171; CG: 2/172,Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Follow‐up: 12–24 months.,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Kono,,,
Leung 2004,"Admitted to ""residential facilities for long‐term placement"" IG: 1/45; CG: 2/47 RR 0.52 (95% CI 0.05 to 5.56)",Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Follow‐up: 12 months. CI: confidence interval; RR. risk ratio.,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Leung,,,
Melis 2008,Days spent in a home for the aged IG: mean 24.0 days (SD 58.0); CG: mean 32.0 days (SD 65.0) MD −8.0 days (95% CI −13.46 to 29.46) Days spent in a nursing home IG: mean 4.0 days (SD 16.0) CG: mean 5.0 days (SD 23.0) MD −1.0 days (95% CI −5.74 to 7.74),Number of participants at baseline: intervention group (IG): 88; control group (CG): 67. Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,Melis,,,
van Hout 2010,Time to institutionalisation IG: 23/331; CG: 20/320 HR 1.04 (95% CI 0.07 to 16.6),"Number of participants at baseline: intervention group (IG): 331; control group (CG): 320. Other outcomes: hospital registry, supplemented with self‐report (hospital admission) and primary care or nursing homes records (institutionalisation). Follow‐up: 18 months. CI: confidence interval; HR: hazard ratio.",,,Case management compared with usual care for change in place of residence to a nursing or residential home,3,van,,,
3.1 Quality of life between 3 and 24 months' follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for quality of life,5,3,1,,Quality of life between 3 and 24 months' follow‐up Show forest plot
Quality of life between 3 and 24 months' follow‐up,Quality of life between 3 and 24 months' follow‐up,Quality of life between 3 and 24 months' follow‐up,,,Case management compared with usual care for quality of life,5,Quality,,of life between 3 and 24 m,
Study,Results,Notes,,,Case management compared with usual care for quality of life,5,Study,,,
Bleijenberg 2016,"RAND‐36 (physical health) 6 months: IG2: mean 59.5 points (95% CI 58.6 to 60.3) CG: mean 58.4 points (95% CI 57.4 to 59.4) 12 months: IG2: mean 58.3 points (95% CI 57.3 to 59.3) CG: mean 56.6 points (95% CI 55.1 to 58.1) RAND‐36 (social health) 6 months: IG2: mean 43.0 points (95% CI 42.3 to 43.8) CG: mean 42.6 points (95% CI 41.6 to 43.6) 12 months: IG2: mean 42.7 points (95% CI 42.1 to 43.2) CG: mean 42.3 points (95% CI 41.7 to 42.9) RAND‐36 (mental health) 6 months: IG2: mean 70.2 points (95% CI 69.4 to 71.1) CG: mean 69.9 points (95% CI 69,0 to 70.8) 12 months: IG2: mean 69.7 points (95% CI 69.0 to 70.4) CG: mean 68.3 points (95% CI 67.5 to 69.2) RAND‐36 (vitality) 6 months: IG2: mean 56.7 points (95% CI 55.8 to 57.6) CG: mean 56.6 points (95% CI 55.5 to 57.5) 12 months: IG2: mean 56.0 points (95% CI 55.1 to 56.9) CG: mean 55.0 points (95% CI 53.7 to 56.3) Perceived quality of life: 6 months: IG2: mean 7.2 points (95% CI 7.2 to 7.3) CG: mean 7.2 points (95% CI 7.1 to 7.2) 12 months: IG2: mean 7.2 points (95% CI 7.1 to 7.3) CG: mean 7.1 points (95% CI 7.0 to 7.2) EQ‐5D: 6 months: IG2: mean 0.78 points (95% CI 0.7 to 0.8) CG: mean 0.8 points (95% CI 0.7 to 0.8) 12 months: IG2: mean 0.7 points (95% CI 0.7 to 0.8) CG: mean 0.7 points (95% CI 0.7 to 0.8)","Number of participants at baseline: intervention group 1 (not analysed in this review): 790; intervention group 2 (IG2): 1446; control group (CG): 856. Instrument: RAND Corporation 36‐item health‐related quality of life instrument (RAND‐36; physical, social, mental, vitality subscales); EuroQol Five‐Dimension Questionnaire (EQ‐5D). Follow‐up: 6 and 12 months. CI: confidence interval.",,,Case management compared with usual care for quality of life,5,Bleijenberg,,,
Cameron 2013,3 months: IG: mean 60.6 points (SD 20.1) CG: mean 60.3 points (SD 16.9) MD 0.3 points (95% CI −4.57 to 5.17) 12 months: IG: mean 57.5 points (SD 20.8) CG: mean 57.7 points (SD 19.7) MD 0.2 points (95% CI −5.23 to 5.63),"Number of participants at baseline: intervention group (IG): 120; control group (CG): 21. Instrument: EuroQol Five‐Dimension Questionnaire Visual Analogue Scale (EQ‐5D‐VAS; vertical scale, scores range from 0–100, higher scores represent better quality of life). Follow‐up: 3 and 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for quality of life,5,Cameron,,,
Gagnon 1999,Physical functioning IG: mean 46.7 points (SD 29.8) CG: mean 44.1 points (SD 29.9) MD 2.6 points (95% CI −4.01 to 9.21) Role‐physical IG: mean 49.0 points (SD 44.1) CG: mean 49.1 points (SD 44.3) MD 0.1 points (95% CI −9.72 to 9.92) Bodily pain IG: mean 56.2 points (SD 33.1) CG: mean 56.4 points (SD 33.8) MD 0.2 points (95% CI −7.21 to 7.61) General health IG: mean 46.2 points (SD 21.6) CG: mean 48.1 points (SD 20.0) MD 1.9 points (95% CI −2.74 to 6.54) Vitality IG: mean 42.9 points (SD 25.7) CG: mean 42.5 points (SD 25.0) MD 0.1 points (95% CI −5.52 to 5.72) Social functioning IG: mean 69.8 points (SD 33.5) CG: mean 68.9 points (SD 34.8) MD 0.9 points (95% CI −6.78 to 8.58) Role‐emotional IG: mean 68.2 points (SD 44.0) CG: mean 62.1 points (SD 46.0) MD 6.1 points (95% CI −3.92 to 16.12) Mental health IG: mean 60.0 points (SD 24.0) CG: mean 59.7 points (SD 23.2) MD 0.3 points (95% CI −4.94 to 5.54),"Number of participants at baseline: intervention group (IG): 212; control group (CG): 215. Instrument: Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36; 10 subscales, scores range from 0–100, higher scores represent better quality of life). Follow‐up: 10 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for quality of life,5,Gagnon,,,
Hoogendijk 2016,"SF‐12 mental health Analysed using linear mixed model analysis adjusting for baseline differences. 1145 participants, 4481 observations Baseline (all groups): 49.9 (10.5) Time‐specific intervention effect B: 6 months: −0.22 (95% CI −0.91 to 0.46) P = 0.52 12 months: 0.34 (95% CI −0.55 to 1.22) P = 0.46 18 months: 0.06 (95% CI −1.08,1.20) P = 0.92 24 months: −0.80 (95% CI −2.31 to 0.72) P = 0.30 Little or no difference between groups regardless of time point. SF‐12 physical health Analysed using linear mixed model analysis adjusting for baseline differences. 1145 participants, 4481 observations Baseline (all groups): 33.8 (9.5) Time‐specific intervention effect B: 6 months: −0.25 (95% CI −0.53 to 1.03) P = 0.53 12 months: −0.37 (95% CI −1.38 to 0.64) P = 0.47 18 months: 0.01 (95% CI −1.29,1.30) P = 0.99 24 months: −0.11 (95% CI −1.83 to 1.61) P = 0.90 Little or no difference between groups regardless of time point. EQ‐5D Analysed using linear mixed model analysis adjusting for baseline differences 1144 respondents (participants), 4556 observations Baseline (all groups): 0.60 (0.28) Time‐specific intervention effect B: 6 months: 0.01 (95% CI −0.01 to 0.03) P = 0.37 12 months: 0.01 (95% CI −0.01 to 0.04) P = 0.24 18 months: 0.03 (95% CI 0.00 to 0.06) P = 0.006 24 months: 0.01 (95% CI −0.03 to 0.05) P = 0.63 Little or no difference between groups regardless of time point.","Instrument: Medical Outcomes Study 12‐item Short‐Form Health Survey (SF‐12); EuroQol Five‐Dimension Questionnaire (EQ‐5D). Follow‐up: 6, 12, 18, and 24 months. CI: confidence interval.",,,Case management compared with usual care for quality of life,5,Hoogendijk,,,
Markle‐Reid 2006,SF‐36 Physical Health Component Summary score IG mean 49.1 points (SD 24.6) CG mean 46.7 points (SD 23.4) MD −1.88 points (95% CI −7.02 to 3.25) SF‐36 Mental Health Component Summary score IG mean 65.1 points (SD 22.4) CG mean 65.2 points (SD 22.1) MD −6.32 points (95% CI −11.04 to −1.59),Number of participants at baseline: intervention group (IG): 144; control group (CG): 44. Instrument: Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36). Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for quality of life,5,Markle‐Reid,,,
Melis 2008,Cantril's Ladder: Authors reported intervention effect difference (D)'s change from baseline at 3 months: 0.39 (95% CI −0.26 to 1.03),Number of participants at baseline: intervention group: 88; control group: 67. Instrument: Cantril's Ladder. Follow‐up: 3 months. CI: confidence interval.,,,Case management compared with usual care for quality of life,5,Melis,,,
Parsons 2012,"Thermometer scale Treatment effect mean: −1.162 (95% CI −3.52 to 1.20) Cognitive performance scale Treatment effect mean: −0.023 (95% CI −0.17 to 0.12) Depression rating scale Treatment effect mean: 0.181 (95% CI −0.07 to 0.43) Changes in health, end‐stage disease and symptoms and signs Treatment effect mean: 0.004 (95% CI −0.10 to 0.11) Pain scale Treatment effect mean: 0.009 (95% CI −0.12 to 0.14)","Number of participants at baseline: intervention group: 169; control group: 182. Instrument: EuroQol (measured as secondary outcome, exact definition not specified, although table 2 indicates that EuroQol was measured as a function of thermometer scale; cognitive performance scale; depression rating scale; changes in health, end‐stage disease and symptoms and signs; and pain scale). Follow‐up: 24 months. CI: confidence interval.",,,Case management compared with usual care for quality of life,5,Parsons,,,
Sandberg 2015,EQ‐5D IG: mean 0.61 points (SD 0.25) CG: mean 0.60 points (SD 0.23) MD 0.01 points (95% CI −0.07 to 0.09) EQ‐5D‐VAS IG: mean 0.61 points (SD 0.17) CG: mean 0.63 points (SD 0.12) MD 0.02 points (95% CI −0.03 to 0.07),Number of participants at baseline: intervention group (IG): 80; control group (CG): 73. Instrument: EuroQol Five‐Dimension Questionnaire (EQ‐5D) and EQ‐5D Visual Analogue Scale (EQ‐5D‐VAS); scores were normalised (divided by 100). Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for quality of life,5,Sandberg,,,
Spoorenberg 2018,EQ‐5D – change from baseline Frail group: IG: mean −0.02 points (SD 0.11) CG: mean 0.0 points (SD 0.12) MD 0.02 points (95% CI −0.01 to 0.05) Complex care needs group: IG: mean −0.02 points (SD 0.17) CG: mean −0.01 points (SD 0.16) MD 0.08 points (95% CI 0.04 to 0.12) EQ‐5D‐VAS Frail group: IG: mean −1.6 points (SD 16.2) CG: mean −2.9 points (SD 12.4) MD 1.3 points (95% CI −2.96 to 5.56) Complex care needs group: IG: mean −0.5 points (SD 16.1) CG: mean 2.0 points (SD 19.9) MD 2.5 points (95% CI −2.06 to 7.06),Number of participants at baseline: stratified into 3 strata: robust (854 participants; excluded from analysis due to not frail population); frail (237 participants); and complex care needs (365 participants). Instrument: EuroQol Five‐Dimension Questionnaire (EQ‐5D) and EQ‐5D Visual Analogue Scale (EQ‐5D‐VAS); scores were normalised (divided by 100). Follow‐up: 12 months. CG: control group; CI: confidence interval; IG: intervention group; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for quality of life,5,Spoorenberg,,,
Suijker 2016,"HRQOL (based on life values) 12 months: IG: mean 0.74 points (95% CI 0.73 to 0.75) CG: mean 0.74 points (95% CI 0.72 to 0.75) EQ‐5D 6 months: IG: mean 0.76 points (95% CI 0.75 to 0.77) CG: mean 0.75 points (95% CI 0.73 to 0.76) 12 months: IG: mean 0.74 points (95% CI 0.72 to 0.75) CG: mean 0.72 points (95% CI 0.69 to 0.72) 18 months: IG: mean 0.75 points (95% CI 0.72 to 0.76) CG: mean 0.71 points (95% CI 0.69 to 0.73) 24 months: IG: mean 0.74 points (95% CI 0.72 to 0.75) CG: mean 0.72 points (95% CI 0.69 to 0.72) EQ5D (estimated mean scores adjusted for baseline outcome) 6 months: IG: mean 0.76 points (95% CI 0.75 to 0.77) CG: mean 0.76 points (95% CI 0.75 to 0.77) 12 months: IG: mean 0.74 points (95% CI 0.73 to 0.75) CG: mean 0.74 points (95% CI 0.69 to 0.72) 18 months: IG: mean 0.74 points (95% CI 0.73 to 0.75) CG: mean 0.72 points (95% CI 0.71 to 0.74) 24 months: IG: mean 0.73 points (95% CI 0.72 to 0.74) CG: mean 0.72 points (95% CI 0.71,0.73) EQ‐5D (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL index score) 6 months: IG: mean 0.76 points (95% CI 0.75 to 0.77) CG: mean 0.76 points (95% CI 0.75 to 0.77) 12 months: IG: mean 0.74 points (95% CI 0.73 to 0.75) CG: mean 0.74 points (95% CI 0.72 to 0.75) 18 months: IG: mean 0.74 points (95% CI 0.73 to 0.75) CG: mean 0.72 points (95% CI 0.71 to 0.74) 24 months IG: mean 0.73 points (95% CI 0.72 to 0.74) CG: mean 0.72 points (95% CI 0.71 to 0.73) Self‐perceived QOL 6 months: IG: mean 7.12 points (95% CI 7.05 to 7.19) CG: mean 7.17 points (95% CI 7.09 to 7.24) 12 months: IG: mean 7.01 points (95% CI 6.93 to 7.10) CG: mean 7.02 points (95% CI 6.94 to 7.11) 18 months: IG: mean 6.98 points (95% CI 6.91 to 7.06) CG: mean 6.97 points (95% CI 6.89 to 7.05) 24 months: IG: mean 6.98 points (95% CI 6.91 to 7.06) CG: mean 6.92 points (95% CI 6.83 to 7.01) Self‐perceived QOL (estimated mean scores adjusted for baseline outcome) 6 months: IG: mean 7.14 points (95% CI 7.08 to 7.20) CG: mean 7.21 points (95% CI 7.16 to 7.27) 12 months: IG: mean 7.04 points (95% CI 6.97 to 7.11) CG: mean 7.07 points (95% CI 6.99 to 7.15) 18 months: IG: mean 7.01 points (95% CI 6.94 to 7.07) CG: mean 7.02 points (95% CI 6.95 to 7.10) 24 months: IG: mean 7.01 points (95% CI 6.95 to 7.07) CG: mean 6.98 points (95% CI 6.90 to 7.06) Self‐perceived QOL (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL index score) 6 months: IG: mean 7.15 points (95% CI 7.09 to 7.21) CG: mean 7.21 points (95% CI 7.15 to 7.27) 12 months: IG: mean 7.05 points (95% CI 7.09 to 7.21) CG: mean 7.21 points (95% CI 7.15 to 7.27) 18 months: IG: mean 7.01 points (95% CI 6.95 to 7.08) CG: mean 7.03 points (95% CI 6.96 to 7.10) 24 months: IG: mean 7.02 points (95% CI 6.96 to 7.08) CG: mean 6.98 points (95% CI 6.90 to 7.06)","Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1074. Instrument: EuroQol Five‐Dimension Questionnaire (EQ‐5D; possible health states were converted in a utility score, using a Dutch general population validation study); self‐perceived quality of life (QOL) assessed using a Cantril's Ladder, where respondents rated their present quality of life on a scale of 0–10. Follow‐up: 6, 12, 18, and 24 months. ADL: activities of daily living; CI: confidence interval: HRQOL: health‐related quality of life.",,,Case management compared with usual care for quality of life,5,Suijker,,,
van Hout 2010,"6 months: IG: mean 44.5 points (SD 10.5) CG: mean 45.4 points (SD 10.6) MD 0.9 points (95% CI −0.72, 2.52) 18 months: IG: mean 43.9 points (SD 11.2) CG: mean 45.2 points (SD 11.2) MD 1.3 points (95% CI −0.42, 3.02)","Number of participants at baseline: intervention group (IG): 331; control group (CG): 320. Instrument: Medical Outcomes Study 36‐item Short‐Form Health Survey (SF‐36; mental component, range 0–100). Follow‐up: 6 and 18 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for quality of life,5,van,,,
4.1 Serious adverse effects between 12 and 24 months follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for serious adverse effects,7,4,1,,Serious adverse effects between 12 and 24 months follow‐up Show forest plot
Serious adverse effects between 12 and 24 months follow‐up,Serious adverse effects between 12 and 24 months follow‐up,Serious adverse effects between 12 and 24 months follow‐up,,,Case management compared with usual care for serious adverse effects,7,Serious,,adverse effects between 12 and 24,
Study,Results,Notes,,,Case management compared with usual care for serious adverse effects,7,Study,,,
Cameron 2013,"Adverse events 2 participants reported back pain that required modification of the intervention, defined as not a major adverse event. Major adverse events attributable to the intervention None reported.",Number of participants at baseline: intervention group: 120; control group: 121. Outcome: number of individuals reporting a medical event or injury that arose as a consequence of participating in the trial. Monitored and recorded by clinicians. Follow‐up: 12 months.,,,Case management compared with usual care for serious adverse effects,7,Cameron,,,
Parsons 2012,"Adverse events There was little or no difference between groups. The trial authors reported no ""noted treatment effect evident on adverse events, including incidence of falls or number of hospitalizations"" but provided no further data.","Number of participants at baseline: intervention group: 169; control group: 182. Outcome: incidence of falls or number of hospitalisations. As reported by the trial authors, no additional data provided. Follow‐up: 24 months.",,,Case management compared with usual care for serious adverse effects,7,Parsons,,,
5.1 Change in physical function between 3 and 24 months' follow‐up Show forest plot,0,,Other data,No numeric data,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,5,1,,Change in physical function between 3 and 24 months' follow‐up Show forest plot
Change in physical function between 3 and 24 months' follow‐up,Change in physical function between 3 and 24 months' follow‐up,Change in physical function between 3 and 24 months' follow‐up,Change in physical function between 3 and 24 months' follow‐up,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Change,,in physical function between 3 and 24 m,
Study,Outcome,Results,Notes,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Study,,,
Applebaum 2002,Physical function,ADLs 6 months: IG: mean 1.23 points; CG: mean 1.35 points 12 months: IG: mean 1.15 points; CG: mean 1.26 points IADLS 6 months IG: mean 3.56 points; CG: mean 4.00 points 12 months: IG: mean 3.58 points; CG: mean 3.42 points Overall health status 6 months: IG: mean 10.5 points; CG: mean 10.3 points 12 months: IG: mean 10.3 points; CG: mean 9.2 points Health status in last month 6 months: IG: mean 11.6 points; CG: mean 11.1 points 12 months: IG: mean 11.0 points; CG: mean 12.0 points Health locus of control 6 months: IG: mean 18.2 points; CG: mean 18.7 points 12 months: IG: mean 18.8 points; CG: mean 18.4 points,Number of participants at baseline: intervention group (IG): 156; control group (CG): 152. Instrument: number of activities of daily living (ADLs) with help (range 0–6); number of instrumental activities of daily living (IADLs) with help (range 0–7); overall health status (range 0–16; lower score means better health); health status in last month (range 0–16; higher score means better health); health locus of control (range 0–26; low score means self‐controlled). Follow‐up: 6 and 12 months.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Applebaum,,,
Bernabei 1998,Physical function,ADLs IG: AdjM 2.0 points (SD 0.99) CG: AdjM 2.6 points (SD 1.00) MD 0.6 points (95% CI 0.32 to 0.88) IADLs IG: AdjM 4.1 points (SD 0.99) CG: AdjM 4.4 points (SD 1.00) MD 0.3 points (95% CI 0.02 to 0.58),"Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Instrument: activities of daily living (ADLs; 6‐item scale, ranging from 0–6) and instrumental activities of daily living (IADLs, 7‐item scale, ranging from 0–7). Scales not described, higher scores indicate greater disability. Follow‐up: 12 months. AdjM: mean adjusted for baseline measures; CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Bernabei,,,
Bleijenberg 2016,Physical function,"6 months: IG2: mean 1.7 points (95% CI, 1.59, 1.80) CG: mean 1.75 points (95% CI, 1.67, 1.82) 12 months: IG2: mean 1.88 points (95% CI 1.80, 1.96) CG: mean 2.03 points (95% CI 1.93, 2.13)","Number of participants at baseline: intervention group 1 (not analysed in this review): 790; intervention group 2 (IG2): 1446; control group (CG): 856. Instrument: ""modified Katz‐15 index of activities of daily living (ADLs) and instrumental activities of daily living (IADLs) (range 0–15)"". Adjusted for practice and participant baseline characteristics. Follow‐up: 6 and 12 months. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Bleijenberg,,,
Cameron 2013,Physical function,Mobility (SPPB) 3 months: IG: mean 5.4 points (SD 2.32) CG: mean 5.72 points (SD 2.3) MD 0.32 points (95% CI −0.29 to 0.93) 12 months: IG: mean 5.83 points (SD 2.82) CG: mean 4.69 points (SD 2.91) MD 1.14 points (95% CI 0.37 to 1.91) ADLs 3 months: IG: mean 94.2 points (SD 11.2) CG: mean 93.2 points (SD 13.9) MD 1.0 points (95% CI −2.32 to 4.32) 12 months IG: mean 89.50 points (SD 17.5) CG: mean 86.1 points (SD 24.7) MD 3.40 points (95% CI −2.35 to 9.15),"Number of participants at baseline: intervention group (IG): 120; control group (CG): 121. Instrument: Short Physical Performance Battery (SPPB; gait speed, chair stand, and balance tests; scores range from 0 to 12, higher scores represent more mobility); activities of daily living (ADLs) measured with Barthel Index (10‐item scores, range 0 to 100, higher scores indicate lower disability). Follow‐up: 3 and 12 months. CI: confidence interval; MD: mean difference.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Cameron,,,
Eklund 2013,Physical function,ADLs – improved 3 months: IG: 42%; CG: 24% OR 2.37 (95% CI 1.20 to 4.68) 6 months: IG: 36%; CG: 28% OR 1.50 (95% CI 0.77 to 2.94) 12 months: IG: 39%; CG: 24% OR 2.04 (95% CI 1.03 to 4.06) ADLs – maintained 3 months: IG: 38%; CG: 43% OR 0.79 (95% CI 0.42 to 1.48) 6 months: IG: 32%; CG: 26% OR 1.30 (95% CI 0.66 to 2.59) 12 months: IG: 24%; CG 29% OR 0.76 (95% CI 0.37 to 1.53) ADLs – decreased 3 months: IG: 20%; CG: 33% OR 0.51 (95% CI 0.25 to 1.04) 6 months: IG: 31%; CG: 46% OR 0.52 (95% CI 0.27 to 0.98) 12 months: IG: 38%; CG: 47% OR 0.67 (95% CI 0.36 to 1.26) Self‐rated health (secondary outcome) Change from 6 to 12 months: Relative rank variance: IG: 0.15 (95% CI 0.06 to 0.24); CG: 0.14 (95% CI 0.04 to 0.24) Sum of symptoms (secondary outcome) Change from 6 to 12 months: Relative rank variance: IG: 0.20 (95% CI 0.10 to 0.31); CG: 0.16 (95% CI 0.04 to 0.27),"Number of participants at baseline: intervention group (IG): 89; control group (CG): 92. Instrument: activities of daily living (ADLs; number of activities managed independently, from 0–9); self‐rated health (""derived from one statement on the Short‐Form Health Survey (SF‐36): ‘In general, you would say your health is. . .’ followed by responses on a five‐point Likert‐type scale: excellent, very good, good, fair or poor.""); sum of symptoms (""Symptoms during the previous three months were assessed by one part of the Goteborg quality of life instrument, with yes or no responses. A summary score of 1–30 symptoms was computed for each participant and scores were transformed into a six‐grade scale with an interval of five symptoms in each grade""). Follow‐up: 3, 6, and 12 months. CI: confidence interval; OR: odds ratio.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Eklund,,,
Gagnon 1999,Physical function,ADLs IG: mean 13.6 points (SD 1.90) CG: mean 13.4 points (SD 2.00) MD 0.2 points (95% CI −0.2 to 0.6) IADLs IG: mean 10.5 points (SD 3.00) CG: mean 10.3 points (SD 3.00) MD 0.2 points (95% CI −0.5 to 0.9),"Number of participants at baseline: intervention group (IG): 212; control group (CG): 215. Instrument: Older American Resources and Services Multidimensional Functional Assessment Questionnaire (OARS; scores range from 0–15 for activities of daily living (ADLs) and from 0–14 for instrumental activities of daily living (IADLs), higher scores indicate lower disability). Follow‐up: 10 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Gagnon,,,
Hoogendijk 2016,Physical function,"ADLs Analysed using linear mixed model analysis adjusting for baseline differences. 1147 respondents (participants), 4574 observations Baseline (all groups): 0.9 (1.2) Time‐specific intervention effect B: 6 months: 0.01 B (95% CI 0.06 to 0.08); P = 0.84 12 months: −0.07 B (95% CI −0.16 to 0.02); P = 0.10 18 months: −0.04 B (95% CI −0.15 to 0.08); P = 0.53 24 months: −0.04 (95% CI −0.19 to 0.11); P = 0.61 Little or no difference between groups regardless of time point. Instrumental ADLS Analysed using linear mixed model analysis adjusting for baseline differences. 1129 respondents (participants), 4443 observations Baseline (all groups):2.6 (1.6) Time‐specific intervention effect B: 6 months: −0.08 (95% CI −0.19 to 0.02); P = 0.13 12 months: −0.11 (95% CI −0.24 to 0.03); P = 0.14 18 months: −0.25 (95% CI −0.43 to −0.07); P = 0.007 24 months: −0.16 (95% CI −0.40 to 0.08); P = 0.19 Little or no difference between groups regardless of time point.",Instrument: Katz Index for activities of daily living (ADLs) and instrumental activities of daily living (IADLs). Follow‐up: 12 months. CI: confidence interval.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Hoogendijk,,,
Kono 2012,Physical function,ADLs 12 months: IG: mean 89.00 points (SD 14.30) CG: mean 89.80 points (SD 15.10) MD 0.80 points (95% CI −2.42 to 4.02) 24 months: IG: mean 88.10 points (SD 14.70) CG: mean 89.0 points (SD 18.70) MD 0.9 points (95% CI −3.21 to 5.01) IADLs 12 months: IG: mean 7.1 points (SD 3.8) CG: mean 7.1 points (SD 3.9) MD 0.0 points (95% CI −2.23 to 2.23) 24 months: IG: mean 7.0 points (SD 3.8) CG: mean 7.0 points (SD 4.0) MD 0.0 points (95% CI −0.95 to 0.95),"Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Instrument: activities of daily living (ADLs) measured with the Barthel Index; instrumental activities of daily living (IADLs) measured with the Tokyo Metropolitan Institute of Gerontology Index of Competence (13 items, scores range from 0–13, higher scores indicate lower disability). Follow‐up: 12 and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Kono 2016,Physical function,ADLs 12 months: IG: mean 91.5 points (95% CI 89.5 to 93.5) CG: mean 91.9 points (95% CI 89.1 to 93.1) 24 months: IG: mean 90.0 points (95% CI 87.8 to 92.2) CG: mean 85.0 points (95% CI 83.0 to 87.0) IADLs 12 months: IG: mean 7.8 points (95% CI 7.4 to 8.2) CG: mean 7.8 points (95% CI 7.4 to 8.2) 24 months: IG: mean 7.4 points (95% CI 6.8 to 8.0) CG: mean 7.3 points (95% CI 6.9 to 7.7),"Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. ADLs: activities of daily living (ADLs) measured with the Barthel Index, reported as adjusted means with 95% CI; instrumental activities of daily living (IADLs) measured with the Tokyo Metropolitan Institute of Gerontology Index of Competence. Follow‐up: 12 and 24 months. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Leung 2004,Physical function,Functional performance – ADLs IG: mean 0.3 points (SD 1.0) CG: mean 0.2 points (SD 1.1) MD 0.1 points (95% CI −0.34 to 0.54) Functional performance – level of transfers IG: mean 0.4 points (SD 1.2) CG: mean 0.2 points (SD 1.0) MD 0.2 points (95% CI −0.26 to 0.66) Functional performance – level of continence IG: mean 0.3 points (SD 0.8) CG: mean 0.0 points (SD 0.2) MD 0.3 points (95% CI 0.06 to 0.54) Participants allocated to IG scored higher on the continence scale (P < 0.05),"Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Instrument: Minimal Data Set‐Home Care (MDS‐HC; 6 subscales, higher scores indicate higher disability). Follow‐up: 12 months. ADLs: activities of daily living; CI: confidence interval; MD: mean difference.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Leung,,,
Melis 2008,Physical function,GARS‐3: 3 months: Authors reported intervention effect difference (D) from baseline to 3 months: −2.2 (95% CI −4.2 to −0.30) 6 months: Authors reported intervention effect difference (D) from baseline to 6 months: −1.6 (95% CI −3.9 to −0.70),"Number of participants at baseline: intervention group (IG): 85; control group (CG): 66. Instrument: Groningen Activity Restriction Scale‐3 (GARS‐3; 18 items covering activities of daily living and instrumental activities of daily living, score ranging from 18–72, higher scores represent more disability) Follow‐up: 3 and 6 months (effect size is change from baseline)",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Melis,,,
Metzelthin 2013,Physical function,GARS 6 months: IG: mean 32.83 points (SD 10.98) CG: 30.16 points (SD 10.07) MD 0.41 points (95% CI −0.80 to 1.62) 12 months: IG: mean 33.08 points (SD 11.34) CG: mean 30.8 points (SD 10.29) MD 0.47 points (95% CI −0.81 to 1.76) 24 months: IG: mean 34.4 points (SD 11.6) CG: mean 31.5 points (SD 10.9) MD 1.18 points (95% CI −0.35 to 2.71) GARS ADL 6 months: IG: mean 17.54 points (SD 5.82) CG: mean 16.17 points (SD 5.13) MD 0.25 points (95% CI −0.44 to 0.94) 12 months: IG: mean 17.81 points (SD 5.90) CG: mean 16.3 points (SD 5.31) MD 0.59 points (95% CI −0.14 to 1.33) 24 months: IG: mean 18.31 points (SD 5.82) CG: mean 16.73 points (SD 5.73) MD 0.77 points (95% CI −0.05 to 1.59) GARS IADL 6 months: IG: mean 15.29 points (SD 5.92) CG: mean 14.0 points (SD 5.51) MD 0.17 points (95% CI −0.63 to 0.97) 12 months: IG: mean 15.28 points (SD 6.03) CG: mean 14.51 points (SD 5.69) MD −0.12 points (95% CI −0.93 to 0.68) 24 months: IG: mean 16.08 points (SD 6.35) CG: mean 14.77 points (SD 5.86) MD 0.4 points (95% CI −0.54 to 1.34),"Number of participants at baseline: intervention group (IG): 193; control group (CG): 153. Instrument: Groningen Activity Restriction Scale (GARS; 18 items covering activities of daily living (ADLs) and instrumental activities of daily living (IADLs), score ranging from 18–72, higher scores represent more disability). Follow‐up: 6, 12, and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Metzelthin,,,
Parsons 2012,Physical Function,"ADLs – short‐form (secondary outcome) Treatment effect mean 0.015 (95% CI −0.21 to 0.24) ADLs – self‐performance (secondary outcome) Treatment effect mean 0.018 (95% CI −0.11 to 0.14) ADLs – long‐form (secondary outcome) Treatment effect mean 0.045 (95% CI −0.43, 0.52) IADLs – difficulty (secondary outcome) Treatment effect mean 0.052 (95% CI −0.14 to 0.25) IADLs – involvement (secondary outcome) Treatment effect mean 0.310 (95% CI 0.04 to 0.58) IADLs – summary (secondary outcome) Treatment effect mean 0.671 (95% CI 0.11 to 1.23)",Number of participants at baseline: intervention group (IG): 169; control group (CG): 182. Instrument: activities of daily living (ADLs); instrumental activities of daily living (IADLs). Follow‐up: 24 months. CI: confidence interval.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Parsons,,,
Spoorenberg 2018,Physical function,"Katz‐15 – Mean change from baseline Frail group: IG: mean 2.36 points (SD 2.40) CG: mean 2.24 points (SD 2.57) MD 0.12 points (95% CI −0.53 to 0.77) Complex care needs group: IG: mean 3.87 points (SD 2.86) CG: mean 4.04 points (SD 3.06) MD 0.17 points (95% CI −0.48, 0.82)","Number of participants at baseline: stratified into 3 strata: robust (854 participants; excluded from analysis due to not frail population); frail (237 participants); and complex care needs (365 participants). Instrument: modified Katz scale (Katz‐15; 15 items covering activities of daily living (ADLs) and instrumental activities of daily living (IADLs), higher scores represent higher disability). Follow‐up: 12 months. CG: control group. CI: confidence interval; IG: intervention group; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Spoorenberg,,,
Suijker 2016,Physical function,"Modified Katz‐ADL Index 6 months: IG: mean 3.11 points (95% CI 2.94 to 3.28) CG: mean 3.32 points (95% CI: 3.13 to 3.50) 12 months: IG: mean 3.38 points (95% CI 3.20 to 3.56) CG: mean 3.59 points (95% CI 3.39 to 3.78) 18 months: IG: mean 3.53 points (95% CI 3.34 to 3.71) CG: mean 3.74 points (95% CI 3.54 to 3.93) 24 months: IG: mean 3.27 points (95% CI 3.09 to 3.45) CG: mean 3.48 points (95% CI 3.28 to 3.67) Katz‐ADL (estimated mean scores adjusted for baseline outcome) 6 months: IG: mean 3.05 points (95% CI 2.94 to 3.15) CG: mean 3.10 points (95% CI 2.98 to 3.21) 12 months: IG: mean 3.33 points (95% CI 3.21 to 3.44) CG: mean 3.38 points (95% CI 3.25 to 3.51) 18 months: IG: mean 3.47 points (95% CI 3.35 to 3.59) CG: mean 3.52 points (95% CI 3.39 to 3.65) 24 months: IG mean 3.20 points (95% CI 3.07 to 3.34) CG: mean 3.26 points (95% CI 3.11 to 3.40) Katz‐ADL (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL Index score) 6 months: IG mean 3.02 points (95% CI 2.92 to 3.12) CG: mean 3.09 points (95% CI 2.98 to 3.21) 12 months: IG mean 3.31 points (95% CI 3.20 to 3.42) CG: mean 3.39 points (95% CI 3.26 to 3.51) 18 months: IG mean 3.46 points (95% CI 3.33 to 3.58) CG: mean 3.53 points (95% CI 3.40 to 3.66) 24 months: IG mean 3.19 points (95% CI 3.05 to 3.66) CG: mean 3.27 points (95% CI 3.12 to 3.41)","Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1074. Instrument: 15‐item modified Katz‐ADL (activities of daily living) Index. Follow‐up: 6, 12, 18, and 24 months follow‐up. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Suijker,,,
van Hout 2010,Physical function,IG: mean 51.8 points (SD 10.40) CG: mean 53.0 points (SD 10.5) MD 1.2 points (95% CI −0.41 to 2.81),"Number of participants at baseline: intervention group (IG): 331; control group (CG): 320. Instrument: Groningen Activity Restriction Scale (GARS; disability in activities of daily living (ADLs) and instrumental activities of daily living (IADLs), range 18–72). Follow‐up: 18 months. CI: confidence interval; MD: mean difference.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,van,,,
"5.2 Change in cognitive, emotional, and social function between 3 and 24 months follow‐up Show forest plot",12,,Other data,No numeric data,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,5,2,,"Change in cognitive, emotional, and social function between 3 and 24 months follow‐up Show forest plot"
"Change in cognitive, emotional, and social function between 3 and 24 months follow‐up","Change in cognitive, emotional, and social function between 3 and 24 months follow‐up","Change in cognitive, emotional, and social function between 3 and 24 months follow‐up","Change in cognitive, emotional, and social function between 3 and 24 months follow‐up",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Change,,"in cognitive, emotional, and social function between 3 and 24",
Study,Outcome,Results,Notes,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Study,,,
Cognitive function,Cognitive function,Cognitive function,Cognitive function,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Cognitive,,,
Bernabei 1998,Mental status,IG: AdjM 2.8 points (SD 1.99) CG: AdjM 3.4 points (SD 2) MD 0.6 points (95% CI 0.04 to 1.16),"Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Instrument: Short Portable Mental Status Questionnaire (SPMSQ; 10 items, scores ranging 0–0, higher scores represent worse cognitive function). Follow‐up: 10 months. AdjM: mean adjusted for baseline measures; CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Bernabei,,,
Kono 2016,Cognitive capacity,12 months: IG: mean change 2.2 points (95% CI 2.0 to 2.4); CG: mean change 2.2 points (95% CI 2.0 to 2.4) 24 months: IG: mean change 2.4 points (95% CI 2.2 to 2.6); CG: mean change 2.2 points (95% CI 2.0 to 2.4),"Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Instrument: Metamemory in Adulthood Questionnaire (MAQ; capacity subscale, 7 items, scores ranging 5–35, higher scores represent better cognitive function). Follow‐up: 12 and 24 months. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Leung 2004,Mental status,IG: mean −0.1 points (SD 1.4) CG: mean −0.2 points (SD 0.8) MD 0.1 points (95% CI −0.37 to 0.57),"Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Instrument: Minimal Data Set‐Home Care (MDS‐HC; mental status subscale, higher scores indicate higher disability). Follow‐up: 12 months CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Leung,,,
Melis 2008,Mental status,MMSE: Authors reported intervention effect difference (D) from baseline to 6 months: −0.5 (95% CI −1.8 to 0.1),Number of participants at baseline: intervention group (IG): 88; control group (CG): 67. Instrument: Folstein Mini Mental State Examination (MMSE). Follow‐up: 6 months CI: confidence interval.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Melis,,,
Emotional function,Emotional function,Emotional function,Emotional function,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Emotional,,,
Applebaum 2002,Mood,6 months: IG: mean 14.90 points CG: mean 15.90 points P < 0.5 12 months IG: mean 15.30 points CG: mean 15.80 points,Number of participants at baseline: intervention group (IG): 156; control group (CG): 152. Instrument: Overall Mood (range 0–20; high score is happier). Follow‐up: 6 and 12 months.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Applebaum,,,
Bernabei 1998,Depression symptoms,IG: AdjM 10.9 points (SD 5.0) CG: AdjM 12.8 points (SD 5.0) MD 1.9 points (95% CI 0.50 to 3.30),"Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Instrument: Geriatric Depression Scale (GDS; 30 items, scores range from 0–30, higher scores represent more depression symptoms). Follow‐up: 12 months. AdjM: mean adjusted for baseline measures; CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Bernabei,,,
Cameron 2013,Depression symptoms,3 months: IG: mean 4.89 points (SD 3.14) CG: mean 4.90 points (SD 3.24) MD 0.01 points (95% CI −0.83 to 0.85) 12 months: IG: mean 4.62 points (SD 3.33) CG: M 4.98 points (SD 3.16) MD 0.36 points (95% CI −0.51 to 1.23),Number of participants at baseline: intervention group (IG): 120; control group (CG): 121. Instrument: Geriatric Depression Scale (GDS). Follow‐up: 3 and 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Cameron,,,
Kono 2012,Depression symptoms,12 months: IG: mean 6.7 points (SD 4.1) CG: mean 6.9 points (SD 4.0) MD 0.2 points (95% CI −0.69 to 1.09) 24 months: IG: mean 7.1 points (SD 4.0) CG: mean 7.2 points (SD 3.8) MD 0.1 points (95% CI −0.88 to 1.06),"Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Geriatric Depression Scale (GDS; short version, 15‐items, scores range 0–15, higher scores represent more depression symptoms). Follow‐up: 12 and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Kono 2016,Depression symptoms,12 months: IG: mean 2.2 points (95% CI 2.0 to 2.4) CG: mean 2.2 points (95% CI 2.0 to 2.4) 24 months: IG: mean 2.2 points (95% CI 2.0 to 2.4) CG: mean 2.2 (95% CI 2.0 to 2.4),"Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Geriatric Depression Scale (GDS; short version, 5‐items, scores range from 0–5, higher scores represent more depression symptoms). Follow‐up: 12 and 24 months. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Leung 2004,Mood symptoms,IG: mean −0.5 points (SD 1.2) CG: mean −0.2 points (SD 0.7) MD 0.3 points (95% CI −0.12 to 0.71),"Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Instrument: Minimal Data Set‐Home Care (MDS‐HC; mood symptoms subscale, higher scores represent more depression symptoms). Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Leung,,,
Markle‐Reid 2006,Depression symptoms,IG: mean 11.9 points (SD 10.2) CG: mean 118.0 points (SD 10.8) MD 2.72 points (95% CI 0.39 to 5.07),Number of participants at baseline: intervention group (IG): 144; control group (CG): 144. Instrument: Center for Epidemiologic Studies Depression Scale (CES‐D). Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Markle‐Reid,,,
Melis 2008,Perceived loneliness,Authors report intervention effect difference (D) from baseline to 3 months: 0.10 (95% CI −0.8 to 0.99),"Number of participants at baseline: intervention group: 88; control group: 67. Perceived loneliness, the de Jong‐Gierveld & Kamphuis Loneliness Scale (range 0–11) Follow‐up: 3 months",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Melis,,,
Metzelthin 2013,Depression symptoms,6 months: IG: mean 5.72 points (SD 3.49) CG: mean 5.82 points (SD 3.88) MD −0.11 points (95% CI −0.80 to 0.58) 12 months: IG: mean 5.68 points (SD 4.13) CG: mean 5.82 points (SD 3.92) MD 0.78 points (95% CI −0.04 to 1.53) 24 months: IG: mean 5.97 points (SD 4.18) CG: mean 6.10 points (SD 3.78) MD −0.07 points (95% CI −0.90 to 0.77),"Number of participants at baseline: intervention group (IG): 193; control group (CG): 153 (numbers refer to approximate analysis for cluster randomised trials). Instrument: Hospital Anxiety and Depression Scale‐depression subscale (HADS‐D; 7 items, scores range 0–21, higher scores represent more depression symptoms). Follow‐up: 6, 12, and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Metzelthin,,,
Suijker 2016,Emotional wellbeing,"RAND‐36 6 months: IG: mean 70.25 points (95% CI 70.2 to 72.29) CG: mean 70.39 points (95% CI 70.31 to 72.41) 12 months: IG: mean 70.08 points (95% CI 68.98 to 71.19) CG: mean 70.33 points (95% CI 69.16 to 71.50) 18 months: IG: mean 70.24 points (95% CI 69.12 to 71.35) CG: mean 69.94 points (95% CI 68.49 to 71.80) 24 months: IG: mean 69.80 points (95% CI 68.67 to 70.92) CG: mean 68.90 points (95% CI 67.71 to 70.09) RAND‐36 (estimated mean scores adjusted for baseline outcome) 6 months: IG: mean 71.25 points (95% CI 70.21 to 72.29) CG: mean 71.39 points (95% CI 70.30 to 72.47) 12 months: IG: mean 70.09 points (95% CI 68.98 to 71.19) CG: mean 70.32 points (95% CI 69.15 to 71.49) 18 months: IG: mean 70.24 points (95% CI 69.13 to 71.35) CG: mean 69.63 points (95% CI 68.48 to 71.79) 24 months: IG: mean 69.80 points (95% CI 68.68 to 70.93) CG: mean 68.89 points (95% CI 67.70 to 70.08) RAND‐36 (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL index score) 6 months: IG: mean 70.12 points (95% CI 70.07 to 72.16) CG: mean 71.50 points (95% CI 70.42 to 72.59) 12 months: IG: mean 69.90 (95% CI 68.79 to 71.01) CG: mean 70.43 points (95% CI 69.26 to 71.60) 18 months: IG: mean 70.14 points (95% CI 69.01 to 71.26) CG: mean 69.80 points (95% CI 68.64 to 70.96) 24 months IG: mean 69.76 points (95% CI 68.63 to 70.90) CG: mean 69.06 points (95% CI 67.87 to 70.25)","Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1704 Instrument: RAND Corporation 36‐item health‐related quality of life instrument (RAND‐36). Follow‐up: 6, 12, 18, and 24 months. ADLs: activities of daily living; CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Suijker,,,
Social function,Social function,Social function,Social function,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Social,,,
Cameron 2013,Social space,3 months: IG: mean 35.5 points (SD 16.1) CG: mean 30.3 points (SD 13.9) MD 5.2 points (95% CI 1.28 to 9.12) 12 months: IG: mean 34.2 points (SD 16.2) CG: mean 30.9 points (SD 5.5) MD 3.3 points (95% CI 0.07 to 6.53),"Number of participants at baseline: intervention group (IG): 120; control group (CG): 121. Instrument: University of Alabama at Birmingham Life Space Assessment (scores range from 0–120, higher scores represent greater life space). Follow‐up: 3 and 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Cameron,,,
Hoogendijk 2016,Social functioning,"Analysed using logistic mixed model analysis adjusting for baseline differences. 1140 respondents (participants), 4455 observations Baseline (all groups): 31.7% Time‐specific intervention effect: 6 months: OR 1.14 (95 CI 0.89 to 1.46); P = 0.31 12 months OR 0.92 (95 CI 0.67 to 1.27); P = 0.62 18 months OR 1.34 (95 CI 0.91 to 1.97); P = 0.14 24 months OR 1.26 (95 CI 0.76 to 2.10); P = 0.37 No difference between groups regardless of time point.",Instrument: poor social functioning. Follow‐up: 12 months CI: confidence interval; OR: odds ratio.,,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Hoogendijk,,,
Kono 2012,Social support,12 months: IG: mean 7.1 points (SD 4.2) CG: mean 6.9 points (SD 4.7) MD 0.2 points (95% CI −0.78 to 1.18) 24 months: IG: mean 7.1 points (SD 4.1) CG: mean 7.3 points (SD 4.5) MD 0.2 points (95% CI −0.85 to 1.25),"Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Instrument: Social Support Scale (scores range from 0–4, higher scores represent more available social support). Follow‐up: 12 and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Kono 2016,Satisfaction with social activity,12 months: IG: mean 33.7 points (95% CI 31.9 to 35.5) CG: mean 36.5 points (95% CI 34.7 to 38.3) 24 months: IG: mean 31.2 points (95% CI 29.4 to 33.0) CG: mean 33.9 points (95% CI 32.1 to 35.7),"Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Instrument: Daily Life Satisfaction related to social activities (14 items, scores range from 14–70, higher scores represent more satisfaction with social activities). Follow‐up: 12 and 24 months. CI: confidence interval.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Kono,,,
Markle‐Reid 2006,Perceived social support,IG: mean 124.9 points (SD 21.9) CG: mean 125.2 points (SD 22.3) MD −5.26 points (95% CI −9.18 to −1.34),"Number of participants at baseline: intervention group (IG): 144; control group (CG): 144. Instrument: Personal Resource Questionnaire (PRQ85; 25‐item subscale, maximum score 175 points, higher scores represent more perceived social support). Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Markle‐Reid,,,
Metzelthin 2013,Social support and participation,Social Support: 6 months: IG: mean 27.03 points (SD 6.36) CG: mean 26.94 points (SD 5.53) MD 0.18 points (95% CI −0.79 to 1.15) 12 months: IG: mean 27.10 points (SD 6.09) CG: mean 27.27 points (SD 6.54) MD −0.12 points (95% CI −1.22 to 0.99) 24 months: IG: mean 26.76 points (SD 5.98) CG: mean 27.35 points (SD 6.27) MD −0.29 points (95% CI −1.37 to 0.79) Social Participation: 6 months: IG: mean 0.4 points (SD 0.36) CG: mean 0.46 points (SD 0.40) MD 0.00 points (95% CI −0.04 to 0.03) 12 months: IG: mean 0.35 points (SD 0.32) CG: mean 0.45 points (SD 0.40) MD −0.05 points (95% CI −0.11 to 0.01) 24 months: IG: mean 0.33 points (SD 0.31) CG: mean 0.44 points (SD 0.45) MD −0.04 points (95% CI −0.11 to 0.04),"Number of participants at baseline: intervention group (IG): 193; control group (CG): 153 (numbers refer to approximate analysis for cluster randomised trials). Instruments: Social Support List (SSL; scores range from 12–48, higher scores indicate more social support). Maastricht Social Participation‐ Consumptive Participation‐ Frequency subscale (MSPP‐CP‐F; scores range from 0‐3 range, higher scores indicate more social participation). Follow‐up: 6, 12, and 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Metzelthin,,,
Sandberg 2015,Social participation,Number of social participation activities IG: median 3.0 (IQR 2 to 5); CG: median 3 (IQR 1 to 4) Total important leisure activities IG: median 12 (IQR 9 to 14); CG: median 11 (IQR 9 to 13),"Number of participants at baseline: intervention group (IG): 80; control group (CG): 73. Instrument: social participation (13 questions, scores range from 0–13, higher scores represent more social participation); performance and importance of leisure activities (17 questions, scoring and direction of instrument unclear). Follow‐up: 12 months IQR: interquartile range.",,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,Sandberg,,,
5.2.1 Cognitive function,4,,Other data,No numeric data,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,5,2,,Cognitive function
5.2.2 Emotional function,10,,Other data,No numeric data,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,5,2,,Emotional function
5.2.3 Social function,7,,Other data,No numeric data,"Case management compared with usual care for change in physical, cognitive, emotional, and social function",9,5,2,,Social function
6.1 Hospital admissions at 12 months' follow‐up Show forest plot,5,2424,"Risk Ratio (M‐H, Random, 95% CI)","0.91 [0.79, 1.05]",Case management compared with usual care for change in health and social care utilisation,12,6,1,,Hospital admissions at 12 months' follow‐up Show forest plot
6.2 Hospital admissions and other health care utilisation data between 6 and 24 months' follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for change in health and social care utilisation,12,6,2,,Hospital admissions and other health care utilisation data between 6 and 24 months' follow‐up Show forest plot
Hospital admissions and other health care utilisation data between 6 and 24 months' follow‐up,Hospital admissions and other health care utilisation data between 6 and 24 months' follow‐up,Hospital admissions and other health care utilisation data between 6 and 24 months' follow‐up,,,Case management compared with usual care for change in health and social care utilisation,12,Hospital,,admissions and other health care utilisation data between 6 and 24 m,
Study,Results,Notes,,,Case management compared with usual care for change in health and social care utilisation,12,Study,,,
Applebaum 2002,Hospital admissions 6 months: IG: 39/140; CG: 43/153 Between 12 and 18 months: IG: 36/111; CG: 30/108,"Number of participants at baseline: intervention group (IG): 156; control group (CG): 152. Follow‐up: 6, 12, and 18 months.",,,Case management compared with usual care for change in health and social care utilisation,12,Applebaum,,,
Bernabei 1998,Cumulative number of days per year spent in nursing home IG: 1087; CG: 2121 Cumulative number of days per year spent in hospital IG: 894; CG: 1367 Number of participants with emergency department attendance IG: 6/99; CG: 17/100 Number of home visits by general practitioners IG: mean 13.1 home visits (SD 0.8) CG: mean 10.2 home visits (SD 1.1) MD 2.9 home visits (95% CI 2.63 to 3.17) Number of nursing care hours IG: mean 13.0 hours (SD 3.0) CG: mean 12.0 hours (SD 3.0) MD 1.0 hours (95% CI 0.16 to 1.84) Number of home support hours IG: mean 120.0 hours (SD 20.0) CG: mean 154.0 hours (SD 29.0) MD 34.0 hours (95% CI 27.03 to 40.97) Meals on wheels IG: mean 54.0 meals on wheels (SD 12.0) CG: mean 39.0 meals on wheels (SD 10.0) MD 15.0 meals on wheels (95% CI 11.91 to 18.09),Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Bernabei,,,
Bleijenberg 2016,Number of hospital admissions IG2: mean 0.27 hospital admissions (95 % CI 0.24 to 0.31) CG: mean 0.33 hospital admissions (95% CI 0.29 to 0.39) General practice out‐of‐hours consultations IG2: mean 0.96 consultations (95% CI 0.78 to 1.19) CG: mean 0.98 consultations (95% CI 0.81 to 1.17) Number of emergency department visits IG2: mean 0.27 emergency department visits (95% CI 0.24 to 0.31) CG: mean 0.33 emergency department visits (95% CI 0.29 to 0.39) Number of consultations in general practice and home visits IG2: mean 9.34 consultations and home visits (95% CI 8.17 to 10.68) CG: mean 7.12 consultations and home visits (95% CI 6.00 to 8.46),Number of participants at baseline: intervention group (not analysed in this review): 790; intervention group 2 (IG2): 1446; control group (CG): 856. Follow‐up: 12 months CI: confidence interval.,,,Case management compared with usual care for change in health and social care utilisation,12,Bleijenberg,,,
Dalby 2000,"Service utilisation – visits to family physician IG: mean 5.2 visits to family physician (SD 4.5) CG: mean 4.0 visits to family physician (SD 3.6) MD 1.2 visits to family physician (95% CI −0.33, 2.73) Service utilisation – visits to specialist IG: mean 1.8 visits to specialist (SD 2.1) CG: mean 1.7 visits to specialist (SD 3.3) MD 0.1 visits to specialist (95% CI −0.92 to 1.12) Service utilisation – visits to emergency department IG: mean 0.4 visits to emergency department (SD 0.6) CG: mean 0.5 visits to emergency department (SD 1.0) MD 0.1 visits to emergency department (95% CI −0.20 to 0.40) Service utilisation – hospital admissions (overnight) IG: mean 0.4 hospital admissions (SD 0.7) CG: mean 0.3 hospital admissions (SD 0.8) MD 0.1 hospital admissions (95% CI −0.18 to 0.38) Service utilisation – length of stay in hospital (days) IG: mean 18.8 days (SD 31.9) CG: mean 10.5 days (SD 10.7) MD 8.3 days (95% CI −0.74 to 17.34) Service utilisation – outpatient procedures IG: mean 0.04 outpatient procedures (SD 0.2) CG: mean 0.01 outpatient procedures (SD 0.1) MD 0.03 outpatient procedures (95% CI −0.03 to 0.09)",Number of participants at baseline: intervention group (IG): 73; control group (CG): 69. Follow‐up: 14 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Dalby,,,
Eklund 2013,Number of patients with at least one hospital admission IG: 52/85; CG: 46/76 Number of patients with at least one home visit (physician) (primary outcome) IG: 25/85; CG: 16/76 Number of patients with at least one visit to an outpatient clinic (nurse) (primary outcome) IG: 71/85; CG: 63/76 Number of patients with at least one home visit (nurse) (primary outcome) IG: 14/85; CG: 10/76,Number of participants at baseline: intervention group (IG): 89; control group (CG): 92. Follow‐up: 12 months.,,,Case management compared with usual care for change in health and social care utilisation,12,Eklund,,,
Gagnon 1999,Mean number of hospitalisations IG: mean 0.5 hospitalisations (SD 0.8) CG: mean 0.4 hospitalisations (SD 0.7) MD 0.1 hospitalisations (95% CI −0.04 to 0.24) Mean hospital length of stay (days) IG: mean 13.0 days (SD 20.7) CG: mean 11.9 days (SD 13.1) MD 1.1 days (95% CI −4.70 to 6.90) Mean number of emergency department admissions IG: mean 1.2 emergency department admissions (SD 2.0) CG: mean 0.9 emergency department admissions (SD 1.2) MD 0.3 emergency department admissions (95% CI −0.01 to 0.61),Number of participants at baseline: intervention group (IG): 212; control group (CG): 215. Follow‐up: 10 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Gagnon,,,
Kono 2012,Hospital admissions IG: 7/161; CG: 6/162,Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Follow‐up: 24 months,,,Case management compared with usual care for change in health and social care utilisation,12,Kono,,,
Kono 2016,Hospital admissions IG: 9/171; CG: 9/172,Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Follow‐up: between 12 and 24 months.,,,Case management compared with usual care for change in health and social care utilisation,12,Kono,,,
Leung 2004,Total number of acute hospital bed‐days IG: mean 9.6 days (SD 12.2) CG: mean 10.7 days (SD 14.8) MD 1.1 days (95% CI −4.53 to 6.73) Total number of rehabilitation hospital bed‐days IG: mean 8.3 days (SD 15.1) CG: mean 18.5 days (SD 51.1) MD 10.2 days (95% CI −5.56 to 25.96 Total number of hospital bed‐days IG: mean 18.0 days (SD 22.6) CG: mean 29.1 days (SD 60.0) MD 11.1 days (95% CI −7.84 to 30.01) Total episodes of unplanned hospital admissions IG: mean 0.3 unplanned hospital admissions (SD 0.6) CG: mean 0.4 unplanned hospital admissions (SD 1.4) MD 0.1 unplanned hospital admissions (95% CI −0.35 to 0.55) Total episodes of hospital admission IG: mean 2.3 hospital admissions (SD 2.5) CG: mean 2.7 hospital admissions (SD 4.0) MD 0.4 hospital admissions (95% CI −0.99 to 1.79) Total number of attendances at emergency room IG: mean 0.3 attendances at emergency room (SD 0.5) CG: mean 0.8 attendances at emergency room (SD 1.5) MD 0.5 attendances at emergency room (95% CI 0.03 to 0.97) Total number of attendances at outpatient department IG: mean 8.3 attendances at outpatient department (SD 10.1) CG: mean 6.9 attendances at outpatient department (SD 8.1) MD 1.4 attendances at outpatient department (95% CI −2.38 to 5.18) Total number of attendances at geriatric day hospital IG: mean 5.0 attendances at geriatric day hospital (SD 9.3) CG: mean 1.5 attendances at geriatric day hospital (SD 4.8) MD 3.5 attendances at geriatric day hospital (95% CI 0.45 to 6.55) Total number of home visits by community nurse IG: mean 24.8 home visits (SD 53.3) CG: mean 7.5 home visits (SD 21.3) MD 17.3 home visits (95% CI 0.62 to 33.98),Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Leung,,,
Melis 2008,"Total number of hospital stays IG: mean 4.0 hospital stays (SD 14.0); CG: mean 6.0 hospital stays (SD 16.0) MD 2.0 hospital stays (95% CI −3.33, to7.33) Physician care: number of health care units used per patient IG: mean 6.4 health care units (SD 8.2); CG: mean 10.7 health care units (SD 8.9) MD 4.3 health care units (95% CI 1.55 to 7.05)",Number of participants at baseline: intervention group (IG): 88; control group (CG): 67 (sample size re‐analysed for cluster design). Follow‐up. 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Melis,,,
Metzelthin 2013,Number of participants receiving outpatient medical services IG: 75/81; CG 62/71 RR 1.06 (95% CI 0.95 to 1.18) Number of participants receiving primary care: General practitioner IG: 71/71; CG: 63/63 RR 1.00 (95% CI 0.97 to 1.03) Practice nurse IG: 70/71; CG: 18/63 RR 3.45 (95% CI 2.33 to 5.10) Occupational therapist IG: 22/71; CG: 4/63 RR 4.88 (95% CI 1.78 to 13.40) Physiotherapist IG: 46/71; CG: 37/63 RR 1.10 (95% CI 0.84 to 1.44),Number of participants at baseline: intervention group (IG): 193; control group (CG): 157. Follow‐up: 12 months. CI: confidence interval; RR. risk ratio.,,,Case management compared with usual care for change in health and social care utilisation,12,Metzelthin,,,
Sandberg 2015,Inpatient care: Total number of hospital stays IG: mean 0.49 hospital stays (SD 0.81) CG: mean 0.48 hospital stays (SD 0.84) MD 0.01 hospital stays (95% CI −0.25 to 0.27) Total length of stay IG: mean 4.6 days (SD 15.4) CG: mean 4.1 days (SD 11.7) MD 0.5 days (95% CI −3.90 to 4.90) Outpatient care: Total number of visits IG: mean 0.4 visits (SD 0.8) CG: mean 0.8 visits (SD 1.6) MD 0.4 visits (95% CI 0.00 to 0.80) Total number of contacts with physicians in outpatient care IG: mean 8.8 contacts (SD 5.6) CG: mean 10.2 contacts (SD 8.2) MD 1.4 contacts (95% CI −0.83 to 3.63),Number of participants at baseline: intervention group (IG): 80; control group (CG): 73. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Sandberg,,,
Suijker 2016,"Hospitalisation 6 months: IG: IR 0.10 (95% CI 0.08 to 0.11); CG: IR 0.11 (95% CI 0.09 to 0.13) 12 months: IG: IR 0.10 (95% CI 0.08 to 0.12); CG: IR 0.11 (95% CI 0.09 to 0.13) 18 months: IG: IR 0.09 (95% CI 0.08 to 0.11); CG: IR 0.10 (95% CI 0.09 to 0.12) 24 months: IG: IR 0.10 (95% CI 0.08 to 0.12); CG: IR 0.11 (95% CI 0.09 to 0.14) Hospitalisation (estimated mean scores adjusted for baseline outcome) 6 months: IG: IR 0.10 (95% CI 0.08 to 0.12); CG: IR 0.11 (95% CI 0.09 to 0.14) 12 months: IG: IR 0.11 (95% CI 0.09 to 0.13); CG: IR 0.12 (95% CI 0.10 to 0.14) 18 months: IG: IR 0.10 (95% CI 0.08 to 0.12); CG: IR 0.12 (95% CI 0.09 to 0.14) 24 months: IG: IR 0.11 (95% CI 0.09 to 0.13); CG: IR 0.13 (95% CI 0.10 to 0.15) Hospitalisation (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL index score) 6 months: IG: IR 0.11 (95% CI 0.09 to 0.13); CG: IR 0.12 (95% CI 0.10 to 0.14) 12 months: IG: IR 0.11 (95% CI 0.09 to 0.13); CG: IR 0.12 (95% CI 0.10 to 0.14) 18 months: IG: IR 0.11 (95% CI 0.09 to 0.13); CG: IR 0.12 (95% CI 0.10 to 0.14) 24 months: IG: IR 0.12 (95% CI 0.09 to 0.14); CG: IR 0.13 (95% CI 0.10 to 0.15) After‐hours GP care 6 months: IG: IR 0.04 (95% CI 0.03 to 0.05); CG: IR 0.07 (95% CI 0.05 to 0.09) 12 months: IG: IR 0.05 (95% CI 0.03 to 0.06); CG: IR 0.06 (95% CI 0.04 to 0.08) 18 months: IG: IR 0.04 (95% CI 0.03 to 0.06); CG: IR 0.06 (95% CI 0.04 to 0.08) 24 months: IG: IR 0.04 (95% CI 0.03 to 0.05); CG: IR 0.07 (95% CI 0.05 to 0.09) After‐hours GP care (estimated mean scores adjusted for baseline outcome) 6 months: IG: IR 0.04 (95% CI 0.03 to 0.05); CG: IR 0.08 (95% CI 0.05 to 0.10) 12 months: IG: IR 0.06 (95% CI 0.04 to 0.08); CG: IR 0.06 (95% CI 0.04 to 0.09) 18 months: IG: IR 0.05 (95% CI 0.03 to 0.06); CG: IR 0.07 (95% CI 0.04 to 0.09) 24 months: IG: IR 0.07 (95% CI 0.05 to 0.10); CG: IR 0.07 (95% CI 0.05 to 0.10) After‐hours GP care (estimated mean scores adjusted for baseline age, sex, socio‐economic status, level of education, and modified Katz‐ADL index score) 6 months: IG: IR 0.04 (95% CI 0.03 to 0.06); CG: IR 0.08 (95% CI 0.06 to 0.11) 12 months: IG: IR 0.06 (95% CI 0.04 to 0.08); CG: IR 0.06 (95% CI 0.04 to 0.08) 18 months: IG: IR 0.05 (95% CI 0.03 to 0.07); CG: IR 0.07 (95% CI 0.05 to 0.09) 24 months: IG: IR 0.08 (95% CI 0.05 to 0.10); CG: IR 0.08 (95% CI 0.05 to 0.10)","Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1074. Follow‐up: 6, 12, 18 and 24 months. ADLs: activities of daily living; CI: confidence interval; GP: general practitioner; IR: incidence rate",,,Case management compared with usual care for change in health and social care utilisation,12,Suijker,,,
van Hout 2010,"≥ 1 hospital admission IG: 163/331; CG: 141/320 ≥ 1 acute hospital visit IG: 128/331; CG: 101/320 OR 1.6 (95% CI 1.04 to 2.4); P = 0.03 ""a higher risk on acute hospital visits was found among persons assigned to the intervention group who had two or more chronic diseases""",Number of participants at baseline: intervention group (IG): 331; control group (CG): 320. Follow‐up: 18 months CI: confidence interval; OR: odds ratio.,,,Case management compared with usual care for change in health and social care utilisation,12,van,,,
6.3 Change in social care utilisation between 6 and 12 months' follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for change in health and social care utilisation,12,6,3,,Change in social care utilisation between 6 and 12 months' follow‐up Show forest plot
Change in social care utilisation between 6 and 12 months' follow‐up,Change in social care utilisation between 6 and 12 months' follow‐up,Change in social care utilisation between 6 and 12 months' follow‐up,,,Case management compared with usual care for change in health and social care utilisation,12,Change,,in social care utilisation between 6 and 12 m,
Study,Results,Notes,,,Case management compared with usual care for change in health and social care utilisation,12,Study,,,
Bernabei 1998,Number of meals received IG: mean 54.0 meals received (SD 12.0) CG: mean 39.0 meals received (SD 10.0) MD 15.0 meals received (95% CI 11.91 to 18.09),Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Bernabei,,,
Melis 2008,Hours of home care IG: mean 88.6 hours (SD 172.4) CG: mean 63.4 hours (SD 77.7) MD 25.2 hours (95% CI −25.765 to 76.17) Days spent at day care IG: mean 6.0 days (SD 21.0) CG: mean 3.0 days (SD 10.0) MD 3.0 days (95% CI −3.26 to 9.26) Number of days when participants received a meal IG: mean 44.0 days (SD 66.0) CG: mean 33.0 days (SD 63.0) MD 11.0 days (95% CI −12.28 to 34.28),Number of participants at baseline: intervention group (IG): 88; control group (CG): 67. Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Melis,,,
Metzelthin 2013,Number of participants receiving professional home care IG: 42/73; CG: 37/65 RR 1.01 (95% CI 0.76 to 1.35) Number of participants receiving informal care IG: 24/84; CG: 21/74 RR 1.01 (95% CI 0.61 to 1.65) Number of participants receiving in‐home modifications IG: 46/75; CG: 40/66 RR 1.01 (95% CI 0.78 to 1.32),Number of participants at baseline: intervention group (IG): 193; control group (CG): 153. Numbers refer to approximate analysis for cluster randomised trials; sample size varies according to number of respondents per each type of service. Follow‐up: 12 months. CI: confidence interval; RR: risk ratio.,,,Case management compared with usual care for change in health and social care utilisation,12,Metzelthin,,,
Sandberg 2015,Use of municipal home services: Hours of help with IADLs IG: mean 20.9 hours (SD 48.7) CG: mean 14.9 hours (SD 29.2) MD 6.0 hours (95% CI −6.98 to 18.98) Hours of help with PADLs IG: mean 13.7 hours (SD 36.3) CG: mean 15.0 hours (SD 52.7) MD 1.3 hours (95% CI −13.05 to 15.65) Hours of help at night IG: mean 2.7 hours (SD 14.6) CG: mean 1.9 hours (SD 7.9) MD: 0.8 hours (95% CI −3.00 to 4.60) Use of municipal home care: Hours of municipal home care (day) IG: mean 15.3 hours (SD 55.8) CG: mean 10.4 hours (SD 34.4) MD 4.9 hours (95% CI −10.08 to 19.88) Hours of municipal home care (evening) IG: mean 1.1 hours (SD 6.8) CG: mean 3.1 hours (SD 11.0) MD 2.0 hours (95% CI −0.89 to 4.89) Hours of municipal home care (night) IG: mean 0.3 hours (SD 2.9) CG: mean 0.0 hours (SD 0.0) MD 0.3 hours (95% CI −0.37 to 0.97) Use of informal care: Hours of help with IADLs IG: mean 200.0 hours (SD 324.0) CG: mean 333.0 hours (SD 445.0) MD 133.0 hours (95% CI 9.41 to 256.59) Hours of help with PADLs IG: mean 23.0 hours (SD 128.0) CG: mean 64.0 hours (SD 390.0) MD 41.0 hours (95% CI −50.07 to 132.07),Number of participants at baseline: intervention group (IG): 80; control group (CG): 73. Follow‐up: 12 months. CI: confidence interval; IADLs; instrumental activities of daily living; MD: mean difference; PADLs: personal activities of daily living; SD: standard deviation.,,,Case management compared with usual care for change in health and social care utilisation,12,Sandberg,,,
"7.1 Change in health service costs, intervention, and other costs between 6 and 36 months' follow‐up Show forest plot",0,,Other data,No numeric data,Case management compared with usual care for change in costs,15,7,1,,"Change in health service costs, intervention, and other costs between 6 and 36 months' follow‐up Show forest plot"
"Change in health service costs, intervention, and other costs between 6 and 36 months' follow‐up","Change in health service costs, intervention, and other costs between 6 and 36 months' follow‐up","Change in health service costs, intervention, and other costs between 6 and 36 months' follow‐up",,,Case management compared with usual care for change in costs,15,Change,,"in health service costs, intervention, and other costs between 6 and 36 m",
Study,Results,Notes,,,Case management compared with usual care for change in costs,15,Study,,,
Applebaum 2002,Physician services costs: IG: USD 160; CG: USD 310 Home health services: IG: USD 74; CG: USD 261 Little or no difference between groups for other costs.,"Number of participants at baseline: intervention group (IG): 156; control group (CG): 152. Other costs: hospice, medical equipment expenditures, Medicare programme, beneficiary payments. Follow‐up: 18 months.",,,Case management compared with usual care for change in costs,15,Applebaum,,,
Bernabei 1998,Community health service costs IG: GBP 744; CG: GBP 919 Difference −19% Nursing home costs IG: GBP 644; CG: GBP 1244 Difference −48% Hospital expenses IG: GBP 1763; CG: GBP 2688 Difference −34%,"Number of participants at baseline: intervention group (IG): 99; control group (CG): 100. Costs calculated using average costs from UK national official statistics (1998); takes into account costs accrued by adding the case managers. Difference between groups as reported by trial authors, insufficient data provided for reanalysis. Follow‐up: 12 months",,,Case management compared with usual care for change in costs,15,Bernabei,,,
Béland 2006,"Cost of care, % increase, IG group only Home healthcare: 64% (95% CI 46 to 83) P < 0.05 Home social care: −22% (95% CI −50 to 7) Inpatient care: −5% (95% CI −23 to 13) ED visits: −10% (95% CI −26 to 7) Alternate level of care: 17% (95% CI −28 to 71) Skilled nursing homes: 3% (95% CI −24 to 47) Mean community care costs IG: mean USD 12,695; CG: mean USD 9301 Difference USD 3394 Institutional care costs IG: USD 23,544; CG: USD 27,314 Difference USD −3,770 Total costs IG: USD 36,240; CG USD 36,614 Difference USD −374",Number of participants at baseline: intervention group (IG): 656; control group (CG): 653. Follow‐up: 12 months CI: confidence interval.,,,Case management compared with usual care for change in costs,15,Béland,,,
Cameron 2013,"Total cost per person IG: mean AUD 25,030 (SD 29,827) CG: mean AUD 22,885 (SD 32,354) MD AUD 2145 (95% CI −6204.94 to 10,494.94)",Number of participants at baseline: intervention group (IG): 120; control group (CG): 121. Costs calculated using local or national costs. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.,,,Case management compared with usual care for change in costs,15,Cameron,,,
Hoogendijk 2016,Difference in costs USD 356 (95% CI −488 to 1134),Cost‐effectiveness analysis using multilevel regression models of intervention compared to usual care. Follow‐up: 24 months. CI: confidence interval.,,,Case management compared with usual care for change in costs,15,Hoogendijk,,,
Kono 2012,"Total healthcare costs IG: mean JPY 2,016,606 (SD 161,432) CG: mean JPY 2,287,450 (SD 200,535) MD JPY 270,844 (95% CI 226,379.49 to 315,308.51)","Number of participants at baseline: intervention group (IG): 161; control group (CG): 162. Costs calculated using records from prefecture‐ and municipality‐level health insurance plans (2007–2008). Analysis of log‐transformed data, as reported by the trial authors; insufficient data provided for reanalysis. Follow‐up: 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Kono,,,
Kono 2016,"Total long‐term care service costs IG: mean JPY 3507 (SD 5400) CG: mean JPY 3562 JPY (SD 5,066) MD JPY 55.0 (95% CI −1122.35 to 1232.35)","Number of participants at baseline: intervention group (IG): 179; control group (CG): 181. Cost calculation not described; currency not described (referred to as ""credits""). Follow‐up: 36 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Kono,,,
Leung 2004,IG: mean USD 155.30 (SD 167) CG: mean USD 139.0 (SD 135),Number of participants at baseline: intervention group (IG): 45; control group (CG): 47. Costs of informal care Follow‐up: 6 months,,,Case management compared with usual care for change in costs,15,Leung,,,
Markle‐Reid 2006,Total costs of all type of health and social services Little or no difference between groups (P = 0.98),Number of participants at baseline: intervention group (IG): 144; control group (CG): 144. Follow‐up: 6 months.,,,Case management compared with usual care for change in costs,15,Markle‐Reid,,,
Melis 2008,"Total care costs IG: mean EUR 9713 (SD 10,205) CG: mean EUR 8952 (SD 9757) MD EUR 761.0 (95% CI −2840.95 to 4362.95)","Number of participants at baseline: intervention group (IG): 85; control group (CG): 66. ""Costs calculated for unit of care, using the Dutch consumer price index figures (2005). Includes costs associated with healthcare services (e.g., hospitalisation, outpatient care), with the intervention, and other costs (e.g., meals on wheels)"". Follow‐up: 6 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Melis,,,
Metzelthin 2013,"Total costs IG: mean EUR 26,503 (SD 27,273) CG: mean EUR 20,550 (SD 18,891) MD EUR 5953 (95% CI −633 to 12,538) Healthcare costs IG: mean EUR 17,664 (SD 18,277) CG: mean EUR 12,963 (SD 10,439) MD EUR 4701 (95% 540 to 8861)","Number of participants at baseline: intervention group (IG): 193; control group (CG): 153. Numbers refer to approximate analysis for cluster randomised trials. Total costs include healthcare costs (hospital, primary care, long‐term care, and prescribed medication), intervention costs (screening, training activities, and implementation), patient and family costs, informal care, and in‐home modifications. Calculated from healthcare registries and self‐report (2010). Follow‐up: 24 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Metzelthin,,,
Sandberg 2015,"Total costs CG: mean EUR 21,920 (SD 32,936) CG: mean EUR 16,762 (SD 17,064) MD EUR 5158 (95% CI −3341.62 to 13,657.62)","Number of participants at baseline: intervention group (IG): 80; control group (CG): 73. Includes healthcare costs, costs associated with the intervention (collected from central records), municipal home care costs (calculated using self‐reported service use), intervention costs (case managers' salaries) and informal care (mix of self‐reported and central records) costs. Follow‐up: 12 months. CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Sandberg,,,
Spoorenberg 2018,"Total costs Frail group: IG: mean EUR 16,413 (SD 19,628) CG: mean EUR 12,261 (SD 14,428) MD EUR 4152 (95% CI 2373.47 to 5930.53) Complex care needs group: IG: mean EUR 24,622 (SD 24,376) CG: mean EUR 19,959 (SD 19,294) MD EUR 4663 (95% CI 2395.33 to 6930.67)","Number of participants at baseline: stratified into 3 strata: robust (854 participants; excluded from analysis due to not frail population); frail (237 participants); and complex care needs (365 participants). Costs were calculated based on health and social care usage, provided by three Dutch sources of reimbursement, as well as self‐reported usage of informal care (2012). Follow‐up: 12 months. CG: control group; CI: confidence interval; IG: intervention group; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for change in costs,15,Spoorenberg,,,
Suijker 2016,Total costs IG: mean EUR 7012 (SE 508) CG: mean EUR 5609 (SE 364),Number of participants at baseline: intervention group (IG): 1209; control group (CG): 1074. EuroQol Five‐Dimension Questionnaire (EQ‐5D) used to calculate quality‐adjusted life years (QALYs) and health care resource use. Follow‐up: 12 months. SE: standard error.,,,Case management compared with usual care for change in costs,15,Suijker,,,
8.1 Participant satisfaction with care between 6 and 12 months' follow‐up Show forest plot,0,,Other data,No numeric data,Case management compared with usual care for patient satisfaction with care,17,8,1,,Participant satisfaction with care between 6 and 12 months' follow‐up Show forest plot
Participant satisfaction with care between 6 and 12 months' follow‐up,Participant satisfaction with care between 6 and 12 months' follow‐up,Participant satisfaction with care between 6 and 12 months' follow‐up,,,Case management compared with usual care for patient satisfaction with care,17,Participant,,satisfaction with care between 6 and 12 m,
Study,Results,Notes,,,Case management compared with usual care for patient satisfaction with care,17,Study,,,
Applebaum 2002,Satisfaction with Medicare Care 6 months: IG: mean 17.50 points CG: mean 17.70 points 12 months: IG: mean 17.60 points CG: mean 17.60 points Satisfaction w/ESP (definition of 'ESP' not given by study investigators) 6 months: IG: mean 26.40 points CG: mean 27.00 points 12 months: IG: mean 26.50 points CG: mean 26.60 All non‐significant differences between groups.,"Number of participants at baseline: intervention group (IG): 156; control group (CG) 152. Instrument: based on ""summary measures from interviews"". Follow‐up: 6 and 12 months.",,,Case management compared with usual care for patient satisfaction with care,17,Applebaum,,,
Bleijenberg 2016,Satisfaction with care 6 months: IG2: mean 8.1 points (95% CI 8.0 to 8.1) CG: mean 8.02 points (95% CI 8.0 to 8.1) 12 months: IG2: mean 8.0 points (95% CI 7.9 to 8.1) CG: mean 7.9 points (95% CI 7.8 to 8.0) P = 0.05; corrected P = 0.29,Number of participants at baseline: intervention group 1 (not analysed in this review): 790; intervention group 2 (IG2): 1446; control group (CG) 856. Instrument: satisfaction with care (range 0–10) Follow‐up: 6 and 12 months. CI: confidence interval.,,,Case management compared with usual care for patient satisfaction with care,17,Bleijenberg,,,
Gagnon 1999,IG: mean 25.0 points (SD 5.2); CG: mean 23.9 points (SD 5.8) MD 1.1 points (95% CI −0.10 to 2.30),"Number of participants at baseline: intervention group (IG): 212; control group (CG) 215. Instrument: Client Satisfaction Questionnaire (CSQ‐8; scores range from 8–32, higher scores represent higher satisfaction with care). Follow‐up: 10 months CI: confidence interval; MD: mean difference; SD: standard deviation.",,,Case management compared with usual care for patient satisfaction with care,17,Gagnon,,,
